Overview of neonatal screening for phenylketonuria in Brazil
DOI:
https://doi.org/10.11606/issn.2176-7262.v49i6p517-525Palabras clave:
Phenylketonurias. Neonatal Screening. Child Health. Metabolism, Inborn ErrorsResumen
Objectives: To present an overview of neonatal screening for phenylketonuria in Brazil. Methodology: An electronic search was made in LILACS, employing the terms “neonatal screening” and “Brazil” and “Phenylketonuria”. Ten papers were selected for reading because they met the established criteria. Results: The studies were conducted in the states of Sergipe, Tocantins, Bahia, Rio de Janeiro, Santa Catarina, Mato Grosso and São Paulo, and the coverage ranged from 32.3% to 95%. Publications on the situation of neonatal screening for phenylketonuria are scarce in several states of our country, making it difficult to generalize and compare the data. Conclusions: Screening for phenylketonuria needs to be improved, especially with regard to the age of starting treatment. It is a complex public health program that requires greater attention to fully achieve its goals and increase its effectivenessDescargas
Los datos de descarga aún no están disponibles.
Descargas
Publicado
2016-12-08
Número
Sección
Artigo de Revisão
Licencia
Cómo citar
1.
Marqui ABT de. Overview of neonatal screening for phenylketonuria in Brazil. Medicina (Ribeirão Preto) [Internet]. 2016 Dec. 8 [cited 2025 Mar. 12];49(6):517-25. Available from: https://periodicos.usp.br/rmrp/article/view/127440